Lars Damstrup
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research, Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials(1997)523 cited
- → Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells(1997)316 cited
- → Clinical development of new drug–radiotherapy combinations(2016)312 cited
- → The type III epidermal growth factor receptor mutation(2001)243 cited
- → Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.(1994)191 cited
- → A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours(2020)117 cited
- → A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours(2018)95 cited
- → Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies(2008)85 cited
- → Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer(2012)83 cited
- → Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis(1999)70 cited